Does treatment of non-obstructing nephrolithiasis reduce recurrent urinary tract infections? A prospective, observational trial from the EDGE consortium.
Connor M Forbes, Karen L Stern, Jamie Finegan, Amy Reed, Gopal Narang, Kevin Wymer, Jonathan Moore, Jonathan Berger, Jonathan Katz, Kimberly Maciolek, Tatsuki Koyama, Aaron Lee, Ben H Chew, Nicole L Miller, Seth K Bechis, Roger L Sur, Ryan S Hsi
{"title":"Does treatment of non-obstructing nephrolithiasis reduce recurrent urinary tract infections? A prospective, observational trial from the EDGE consortium.","authors":"Connor M Forbes, Karen L Stern, Jamie Finegan, Amy Reed, Gopal Narang, Kevin Wymer, Jonathan Moore, Jonathan Berger, Jonathan Katz, Kimberly Maciolek, Tatsuki Koyama, Aaron Lee, Ben H Chew, Nicole L Miller, Seth K Bechis, Roger L Sur, Ryan S Hsi","doi":"10.5489/cuaj.9741","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Existing studies link kidney stone treatment to reduced recurrent urinary tract infections (UTIs); however, these studies are limited by their retrospective design and/or lack of comparison group. The present study assesses a prospective, observational cohort of patients with recurrent UTIs who selected observation or intervention for management of their non-obstructing kidney stones to assess for impact on UTI recurrence.</p><p><strong>Methods: </strong>From 2020-2025, patients with non-obstructing kidney stones and recurrent UTIs were prospectively enrolled at four centers. After shared decision-making, participants underwent observation or surgical intervention. The primary outcome was UTI recurrence at 12 months post-enrollment, defined as presence of urinary tract symptoms with positive urine culture. The study was powered to detect a 50% reduction in the rate of UTI recurrence between the groups at 12 months.</p><p><strong>Results: </strong>Among 94 patients recruited, followup data at 12 months was available for 21 observation and 46 intervention patients. There were more staghorn stones in the intervention group (15.2% vs. 0%), and the median stone size was larger (13.5 vs. 6 mm). At 12 months, 81% (n=17) in the observation group and 54% (n=25) in the intervention group had a symptomatic UTI recurrence (p=0.06, non-significant). The subgroup (n=17) of stone-free intervention patients had fewer UTI recurrences compared to the observation group (odds ratio 0.12, 95% confidence interval 0.02-0.66). Causation cannot be confirmed due to the observational nature of the study.</p><p><strong>Conclusions: </strong>For patients with recurrent UTIs and stones, surgical intervention is not associated with decreased risk of UTI recurrence at 12 months overall; however, patients who were stone-free after intervention had significantly fewer UTI recurrences on subgroup analysis.</p>","PeriodicalId":50613,"journal":{"name":"Cuaj-Canadian Urological Association Journal","volume":"20 10","pages":"335-341"},"PeriodicalIF":2.0000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13660807/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cuaj-Canadian Urological Association Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5489/cuaj.9741","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Existing studies link kidney stone treatment to reduced recurrent urinary tract infections (UTIs); however, these studies are limited by their retrospective design and/or lack of comparison group. The present study assesses a prospective, observational cohort of patients with recurrent UTIs who selected observation or intervention for management of their non-obstructing kidney stones to assess for impact on UTI recurrence.
Methods: From 2020-2025, patients with non-obstructing kidney stones and recurrent UTIs were prospectively enrolled at four centers. After shared decision-making, participants underwent observation or surgical intervention. The primary outcome was UTI recurrence at 12 months post-enrollment, defined as presence of urinary tract symptoms with positive urine culture. The study was powered to detect a 50% reduction in the rate of UTI recurrence between the groups at 12 months.
Results: Among 94 patients recruited, followup data at 12 months was available for 21 observation and 46 intervention patients. There were more staghorn stones in the intervention group (15.2% vs. 0%), and the median stone size was larger (13.5 vs. 6 mm). At 12 months, 81% (n=17) in the observation group and 54% (n=25) in the intervention group had a symptomatic UTI recurrence (p=0.06, non-significant). The subgroup (n=17) of stone-free intervention patients had fewer UTI recurrences compared to the observation group (odds ratio 0.12, 95% confidence interval 0.02-0.66). Causation cannot be confirmed due to the observational nature of the study.
Conclusions: For patients with recurrent UTIs and stones, surgical intervention is not associated with decreased risk of UTI recurrence at 12 months overall; however, patients who were stone-free after intervention had significantly fewer UTI recurrences on subgroup analysis.
现有研究将肾结石治疗与减少复发性尿路感染(uti)联系起来;然而,这些研究受到回顾性设计和/或缺乏对照组的限制。本研究对复发性尿路感染患者的前瞻性观察队列进行了评估,这些患者选择观察或干预治疗其非梗阻性肾结石,以评估对尿路感染复发的影响。方法:从2020-2025年,在四个中心前瞻性纳入非梗阻性肾结石和复发性尿路感染患者。共同决策后,参与者接受观察或手术干预。主要终点是入组后12个月尿路感染复发,定义为存在尿路症状且尿培养阳性。该研究发现,12个月时两组间尿路感染复发率降低了50%。结果:94例患者中,观察组21例,干预组46例,随访12个月。干预组鹿角结石较多(15.2% vs. 0%),中位结石尺寸较大(13.5 vs. 6 mm)。12个月时,观察组81% (n=17)、干预组54% (n=25)有症状性尿路感染复发(p=0.06,无统计学意义)。无结石干预患者亚组(n=17)与观察组相比,UTI复发较少(优势比0.12,95%可信区间0.02-0.66)。由于研究的观察性质,因果关系无法确定。结论:对于复发性尿路感染和结石患者,手术干预与总体12个月尿路感染复发风险降低无关;然而,亚组分析显示,干预后无结石患者的尿路感染复发明显减少。
期刊介绍:
CUAJ is a a peer-reviewed, open-access journal devoted to promoting the highest standard of urological patient care through the publication of timely, relevant, evidence-based research and advocacy information.